Aparato digestivo
Especialidad
Vicent
Hernández Ramírez
Publications dans lesquelles il/elle collabore avec Vicent Hernández Ramírez (34)
2023
-
Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU
American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046
2022
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
2021
-
Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study
Journal of Clinical Medicine, Vol. 10, Núm. 13
2020
-
Validation of miR-1228-3p as housekeeping for microRNA analysis in liquid biopsies from colorectal cancer patients
Biomolecules, Vol. 10, Núm. 1
-
Variation in Colonoscopy Performance Measures According to Procedure Indication
Clinical Gastroenterology and Hepatology, Vol. 18, Núm. 5, pp. 1216-1223.e2
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12
-
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Journal of Crohn's & colitis, Vol. 13, Núm. 12, pp. 1492-1500
-
Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer (Clinical and Translational Gastroenterology, (2019) 10, e-00031, 10.14309/ctg.0000000000000003)
Clinical and Translational Gastroenterology
-
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
Clinical and translational gastroenterology, Vol. 10, Núm. 1, pp. e00003
2018
-
Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial
United European Gastroenterology Journal, Vol. 6, Núm. 10, pp. 1527-1537
-
Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia
United European Gastroenterology Journal, Vol. 6, Núm. 1, pp. 123-130
-
Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox
United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629
-
Plasma miRNAs signature validation for early detection of colorectal cancer
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v106
2017
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
2016
-
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
BMC Medicine, Vol. 14, Núm. 1
-
Endoscopist characteristics that influence the quality of colonoscopy
Endoscopy, Vol. 48, Núm. 3, pp. 241-247
-
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening
Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551
-
Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines
Endoscopy, Vol. 48, Núm. 11, pp. 995-1002